PHIO icon

Phio Pharmaceuticals

17 hedge funds and large institutions have $132K invested in Phio Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
PAM
1
Panagora Asset Management
Massachusetts
$34K 70,187 -15,153 -18%
TSS
2
Two Sigma Securities
New York
$28K 59,258 +26,889 +83%
Millennium Management
3
Millennium Management
New York
$16K 33,475 +33,475 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$12K 26,638
Vanguard Group
5
Vanguard Group
Pennsylvania
$10K 19,944
Goldman Sachs
6
Goldman Sachs
New York
$9K 18,146 +18,146 New
Citadel Advisors
7
Citadel Advisors
Florida
$7K 15,399 -32,768 -68%
Northern Trust
8
Northern Trust
Illinois
$6K 11,724
RJFSA
9
Raymond James Financial Services Advisors
Florida
$5K 10,433
BlackRock
10
BlackRock
New York
$5K 10,902 +399 +4%
BDWM
11
Brewin Dolphin Wealth Management
Ireland
$5 10 +10 New
UBS Group
12
UBS Group
Switzerland
-33,389 Closed
Hudson Bay Capital Management
13
Hudson Bay Capital Management
Connecticut
-22,300 Closed
Bank of New York Mellon
14
Bank of New York Mellon
New York
-10,568 Closed
FC
15
Ferris Capital
Massachusetts
-3,783 Closed
Creative Planning
16
Creative Planning
Kansas
-2,000 Closed
BC
17
Barnett & Company
Tennessee
-29 Closed
AG
18
Advisor Group
Arizona
$0 163
Deutsche Bank
19
Deutsche Bank
Germany
$0 2
IA
20
IFP Advisors
Florida
$0 1
LTFS
21
Ladenburg Thalmann Financial Services
Florida
$0 38
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$0 7 +7 New
Bank of America
23
Bank of America
North Carolina
$0 702 +33 +5%